Itron has a consensus target price of $84.40, indicating a potential upside of 19.55%. Given Itron's higher possible upside, analysts clearly believe Itron is more favorable than Aehr Test Systems. Volatility and Risk. Aehr Test Systems has a beta of 0 ...
more»